If it keep dropping it may become takeover target. Year ago it was trading at $1.50 share but hype with cloud company has reduced. It going to be valued on real earning going forward. Still not bad investment.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025